Essilor And Gladwin Agree To Settle IP Infringement Litigation
By Essilor News
September 13, 2016
Charenton-le-Pont - September 13, 2016 – Essilor International, Essilor of America, Satisloh and DAC Vision, on one side, and JDP Holdings, and Yangzhou Gladwin M&E Tech. Co., Ltd., on the other side today announced an agreement to settle pending Intellectual Property infringement litigation leading to the withdrawal of accused Gladwin products from the market and dismissal of the lawsuit pending in U.S. district court.
In recognition of the validity and scope of Essilor’s and Satisloh’s asserted patents and trademarks, the parties were able to reach settlement.
The terms of the out-of-court settlement are confidential.
The world's leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, Eyezen™, Xperio®, Foster Grant®, Bolon™ and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals.
Essilor reported consolidated revenue of more than €6.7 billion in 2015 and employs 61,000 people worldwide. It markets its products in more than 100 countries and has 32 plants, 490 prescription laboratories and edging facilities, as well as five research and development centers around the world. For more information, please visit www.essilor.com.
The Essilor share trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices.
Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP